← The SEC Ephemeris: the whole map
Hugel, Inc letibotulinumtoxinA
In the graph: all 2 documents (4 pages).
- Application
- BLA 761225
- Ticker
- Hugel, Inc
- Product
- letibotulinumtoxinA
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- April 12, 2023 · March 31, 2022
From FDA letters and SEC filings. Not investment or medical advice.